Effect of the SGLT-2 Inhibitor Dapagliflozin on Impaired Awareness of Hypoglycemia in Type 1 Diabetes
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2019
Price : $35 *
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 12 Sep 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2019.
- 01 Feb 2019 Status changed from not yet recruiting to recruiting.
- 20 Jun 2018 New trial record